High-throughput cupric ion reducing antioxidant capacity (CUPRAC) methods were developed for assessment of total antioxidant capacity (TAC) in urine and serum, based on reduction of Cu(II)-neocuproine complex to highly colored Cu(I)-neocuproine complex, measured spectrophotometrically at 450 nm. The reaction time was significantly reduced from 30 to 4 min by application of a calibration compound (uric acid) with kinetic behavior similar to that shown by urine samples. The method was implemented in a microformat (96 well plates) and also in an automatic fashion (flow injection analysis, FIA). A determination throughput value of 288 h -1 (microplate method) or of 15 h -1 (automatic FIA) was attained. Application of both methods to human serum (SRM 909b, level I) and urines (n = 9) provided TAC values in agreement with those of the end-point batch method.
Introduction
Reactive oxygen and nitrogen species are able to display beneficial and harmful effects in biological systems under physiological and pathological levels, respectively. 1 Indeed, as evidence of this last situation, oxidative stress state emerges whenever natural antioxidant protection of the living organisms, including endogenous and dietary compounds, is defeated by those reactive species. 2 As a consequence, several clinical conditions such as cancer, cardiovascular diseases, inflammatory states and also neurodegenerative disorders are strongly promoted. 3 For this reason, the assessment of total antioxidant capacity (TAC) of biological fluids will be a useful biomedical tool that can assist the evaluation of physiological, environmental and nutritional factors that influence the human redox status. 4 In this regard, several human biological fluids have been used as samples for the in vitro evaluation of TAC, including plasma, [5] [6] [7] [8] [9] [10] [11] [12] serum, [13] [14] [15] [16] urine, 8, 12, 17 saliva, 15 cerebrospinal fluid, 18 tears, 19 breast milk 20 and also semen. 21 Various batch methodologies based on electron spin resonance (ESR), 10 electrochemical, 6 ,11 chemiluminescence (CL), 8, 15, 16 fluorometric, 7 and UV-Vis spectrophotometric 5, 13, 14 detection have been proposed.
Among these methods, cupric ion reducing antioxidant capacity (CUPRAC) method is a feasible and simple alternative. 13 This assay is based on reduction of Cu(II)-neocuproine complex to highly colored Cu(I)-neocuproine complex by antioxidants present in samples. 22 The CUPRAC method have been applied to human serum, 13 food 23, 24 and plant matrices, 25 and also for determining both hydrophilic and lipophilic antioxidant components by addition of methyl-β-cyclodextrin to the reaction media. 26 It has also been used in a flow format for on-line HPLC postcolumn CUPRAC assessment, 25 but no automatic application for TAC assessment has been reported so far.
Compared to other TAC methods, the CUPRAC batch method presents some advantages: in particular, the reaction pH (7.0) is close to the physiological pH (7.4) , when compared to ferric reducing ability of plasma-FRAP (pH ~3) 5 or to chemiluminescence based methods (pH > 8.5). 8 CUPRAC reagent is fast enough to oxidize thiol-type antioxidants, while simple sugars and citric acid do not reduce the reagent. Moreover, the oxidant species [Cu(Nc)2] 2+ is much more stable and more easily accessible than the synthetic chromogenic radical species (ABTS •+ and DPPH
• ) usually applied for TAC assessment in other type of matrices. 27, 28 Another advantage is the application of spectrophotometric detection, especially when compared to high cost, high maintenance detectors for ESR, 10 for instance.
Therefore, the main objective of the present work was the development of high-throughput and automatic methods for the assessment of TAC in biological samples using CUPRAC assay. Though automation of TAC assays 29, 30 or of assays for assessing scavenging capacity against biologically relevant species 31 have been reported, no automatic method based on CUPRAC for this determination has been proposed so far. Hence, CUPRAC features in flow injection analysis (FIA) mode were evaluated in this work, after the study of reaction conditions and application to compounds with known antioxidant activity. Comparison with batch CUPRAC method under microplate format was also established, through application to biological samples, namely urine and serum.
Experimental

Chemicals and reagents
All chemicals used were of analytical reagent grade with no further purification. Copper(II) chloride dihydrate, ammonium acetate, caffeic acid and L-glutathione reduced (GSH) were purchased from Aldrich (Milwaukee, WI). Neocuproine hydrochloride monohydrate (Nc), gallic acid, Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid), and borax were obtained from Fluka (Buchs, Switzerland). Uric acid, L-cysteine, and bromothymol blue were purchased from Sigma (St. Louis, MO). Hydrochloride acid was obtained from Merck (Darmstadt, Germany) and sodium hydroxide was purchased from Pronalab (Lisbon, Portugal). Standard reference material of lyophilized human serum (SRM 909b, level I) was obtained from LGC Standards S.L.U. (Barcelona, Spain).
Water from Milli-Q system (resistivity > 18 MΩ cm) was used for the preparation of solutions and buffers. Ethanol absolute pro analysis was also used.
For the CUPRAC-FIA methodology, the chromogenic oxidizing solution of [Cu(Nc)2] 2+ (8.4 mM Cu(II) + 6.3 mM Nc) was prepared by dissolving 1.432 g of CuCl2·2H2O and 1.655 g of Nc in water and diluting to 1000 mL. Ammonium acetate buffer 0.88 M (pH 7.0) was prepared by weighing 67.84 g of the solid salt and dissolving it in 1000 mL of water.
For CUPRAC batch method, copper solution (10 mM) and neocuproine solution (7.5 mM) were prepared individually by dissolving 34.1 mg of CuCl2·2H2O and 39.4 mg of Nc in 20 mL of water, respectively. Ammonium acetate buffer 1.0 M (pH 7.0) was also prepared by weighing 38.54 g of ammonium acetate and dissolving it in 500 mL of water.
The stock solution of uric acid (1000 μM) was prepared by dissolving 16 .81 mg in 20 mL of 0.01 M NaOH. The excess of base was then neutralized with dropwise addition of 0.01 M HCl until reaching pH 7.0. Finally, the volume was completed to 100 mL with water. Stock solutions of GSH (1000 μM), cysteine (1000 μM), Trolox (500 μM) and gallic acid (1000 μM) were prepared by dissolving the respective compound in water. Stock solution of caffeic acid (1000 μM) was prepared in ethanol solution 50% (v/v). Working standard solutions were prepared by rigorous dilution of the respective stock solution in water.
For the determination of dispersion coefficient of Ruzicka, a bromothymol blue (BTB) solution was prepared from a stock solution (400 mg L -1 ) by dilution in 0.01 M borax solution.
Flow manifold and instrumentation
The automatic flow injection system designed for determination of total antioxidant capacity of biological fluids is depicted in Fig. 1 . The manifold comprised a Gilson (Villiers-le-Bel, France) Minipuls 3 peristaltic pump with four channels, a Valco (VICI AG International, Schenkon, Switzerland) Cheminert C2-2346E six-port rotary injection valve equipped with a 200-μL loop, a mixing coil (MC, 50 cm) and also a reaction coil (RC, 600 cm) immersed in a thermostatic bath at 37 C (I.S. Co GTR 190, Milan, Italy). All tubing connecting the different components of FIA system was made from polytetrafluoroethylene (Omnifit, Cambridge, UK) with 0.8 mm i.d., except for the connection between the injection valve and the flow network, which was made of polyetheretherketone (PEEK), with 0.75 mm i.d. End-fittings and Y-shaped confluences from Omnifit were also used.
As our detection system, a Jenway (Essex, UK) 6300 UV-vis spectrophotometer equipped with a Model 178.710 QS Hellma (Mullheim/Baden, Germany) flow-through cell (internal volume, 80 μL; optical path, 10 mm) was used. Absorbance measurements were carried out at 450 nm and registered on a Kipp & Zonen (Delft, Netherlands) strip chart recorder.
For CUPRAC batch method, a Synergy HT (Bio-Tek, Winooski, VT) 96-well microplate reader was applied.
CUPRAC-FIA method
In the proposed CUPRAC-FIA system ( Fig. 1 ), three channels of the peristaltic pump were required. Briefly, the chromogenic oxidizing reagent [Cu(Nc)2] 2+ (R1, 8.4 mM Cu(II) + 6.3 mM Nc) and buffer solution (R2, 880 mM, pH 7) were pre-mixed at mixing coil (MC) and then this mixture was added to a 200-μL plug (antioxidant or sample), which was inserted in the carrier stream (H2O) by the injection valve. Afterwards, antioxidants reduce the oxidizing reagent to [Cu(Nc)2] + complex along the reaction coil. The amount of colored complex formed was detected spectrophotometrically at 450 nm. Flow rates of 0.54, 0.24 and 0.23 mL min -1 were applied to carrier (H2O), chromogenic reagent and buffer solution channels, respectively. Before the analytical measurement was started, the spectrophotometric baseline signal was adjusted to zero by propelling the mixture of the three channels through the flow cell. Prior to the determination of CUPRAC values, control experiments were carried out to evaluate interference from intrinsic absorption of antioxidant compounds or samples. For this, [Cu(Nc)2] 2+ solution was replaced by water. All experiments were performed in triplicate and the temperature of the reaction coil was kept at 37 C.
In order to estimate sample dilution in the FIA system, we determined the dispersion coefficient of Ruzicka. 32 For this, all solutions propelled by the peristaltic pump were replaced by borax solution and BTB solution was injected as sample and measured at λ = 620 nm. The ratio between the absorbance signal from undiluted BTB and that processed through the flow system provided a Dsample value of 5.0 for 200 μL injection volume.
CUPRAC microplate batch method
The CUPRAC batch methodology described by Apak et al. 13 to assess the TAC of human serum was adapted with some modifications to 96-well microplate format. Hence, 50 μL of each solution were placed in each well in the following order: copper(II) solution (10 mM), neocuproine solution (7.5 mM) and buffer solution (1000 mM, pH 7). The 96 well-plate was then pre-incubated at 37 C for a period of 15 min, followed by the addition of 100 μL of antioxidant solution or sample. Subsequently, the absorbance of the orange complex formed was monitored every minute during 30 min. To evaluate the intrinsic absorption of antioxidant molecules or samples, we added 100 μL of water instead of copper and neocuproine solutions. Reagent blank was also evaluated by replacing the antioxidant solution or sample by 100 μL of water. All experiments were performed in quadruplicate, keeping the temperature at 37 C.
Sample analysis
Human urine samples were provided by healthy volunteers and analyzed within 2 h after collection. All samples were filtrated before analysis through 0.45 μm Millex-HV filters (Millipore, ref. SLGVX13NL) and diluted with water. The standard reference material of lyophilized human serum was prepared according to the instructions for use reported in the certificate of analysis from National Institute of Standards and Technology.
For analysis of biological samples, calibration curves relating absorbance and concentration of uric acid (12.5 to 200 μM for CUPRAC-FIA and 12.5 to 125 μM for CUPRAC batch methodology) were established. The absorbance value obtained for a diluted sample was converted to uric acid equivalents, expressed in mM, which represented the total antioxidant capacity present in the diluted sample. Finally, this result was multiplied by the appropriate dilution factor.
Results and Discussion
Development of CUPRAC-FIA system
In order to implement CUPRAC method under FIA format, we studied the influence of several operational conditions upon method sensitivity using a univariate approach; these conditions included temperature, form and length of the reaction coil and sample volume. Uric acid was selected as the standard compound and calibration curves were established by plotting the absorbance value as a function of uric acid concentration.
The effect of temperature on sensitivity was assessed using a reaction coil of 600 cm (figure eight configuration) with 1 mL min -1 as total flow rate. The injection volume was fixed at 100 μL and the concentration of uric acid was varied from 25 to 375 μM. The sensitivity obtained was 1.36 and 1.97 mM -1 when 25 and 37 C was tested, respectively. As an increase of 45% in sensitivity was achieved when applying 37 C, and considering that this temperature corresponds to physiological conditions, further experiments were carried out at 37 C.
The influence of reaction coil length on the sensitivity was studied by varying also the total flow rate applied, in order to maintain the same residence time of the reaction mixture inside RC. Taking into account that the residence time was 3 min and that the inner diameter of the tubing was 0.8 mm, we tested three combinations of total flow rate and length of reaction coil: (1 mL min -1 ; 600 cm), (1.5 mL min -1 ; 900 cm) and (2 mL min -1 ; 1200 cm), using the operation conditions described above. When RC was 600 cm long, the slope of the calibration curve was 2.04 mM -1 . The sensitivity obtained was 107 and 93% when RC was 900 and 1200 cm long, respectively. Despite the small improvement of sensitivity obtained with RC of 900 cm, this length was not chosen to further experiments since it will implicate a larger consumption (about 50% more) of reagents than that spent with the reaction coil of 600 cm, due to the higher flow rate applied. Therefore a compromise between sensitivity and consumption of chromogenic oxidizing reagent was made and 600 cm was selected as length of reaction coil.
Finally, the influence of sample volume was assessed by changing the injection loop between 50 and 400 μL. When 50 μL was applied, the slope of the calibration curve was 1.06 mM -1 . The sensitivity was 1.9, 2.6, 3.5, 4.7 and 6.0 times higher when 100, 150, 200, 300 and 400 μL was used, respectively (Fig. 2) .
A linear relationship between the normalized slope (assuming 50 μL as 100%) and the volume injected was observed up to 200 μL. Therefore, 200 μL was chosen for further application because it provided the highest sensitivity that could be decreased in a proportional way by decreasing the sample volume.
Application to antioxidant compounds and evaluation of reaction kinetics
The cupric reducing antioxidant capacity of compounds, with known antioxidant properties, that are usually found in biological fluids was assessed by the developed CUPRAC-FIA system and by the original batch assay 13 under microplate format. The compounds chosen included endogenous molecules such as GSH, cysteine and uric acid and also dietary bioactive phenolic molecules like gallic and caffeic acids. 33 Trolox, a water soluble analogue of vitamin E, was also studied as it is widely used as a standard compound in antioxidant assays. 34 The analytical signals obtained for each antioxidant compound, tested at different concentrations, were measured every minute during 30 min in the microplate batch assay and 4 min after sample injection using the developed CUPRAC-FIA system. Two different kinetic profiles were observed as shown in Fig. 3 . Comparing the slopes of the calibration curves established in the batch method at 4 and 30 min gave the same profiles (Table 1) . For GSH, cysteine and Trolox, designated as fast reacting compounds, the color development was fast, providing a constant absorbance value throughout the analysis, evidenced by similar slopes (relative difference < 2%). On the other hand, the analytical signals of uric acid, gallic acid and caffeic acid increased up to 20 min, reaching then a plateau. Indeed, the results indicated an increase of 37, 13 and 51% of sensitivity for uric acid, gallic acid and caffeic acid, respectively when the analysis time changed from 4 to 30 min. Moreover, when comparing slope values from CUPRAC batch assay after 4 min with those attained for CUPRAC-FIA system, a constant ratio of 1.5 was observed (Table 1 ). This indicates that reaction kinetics did not influence the results obtained by application of either FIA or batch methods because the constant ratio value >1 was caused by the higher sample dilution in CUPRAC-FIA system (D ~5) when compared to the batch method (sample dilution of 2.5 times).
Furthermore, the results obtained for batch end-point measurements at 30 min correspond to previous observations where Trolox showed two times higher TAC values when compared to that observed for thiol-containing molecules (GSH and cysteine, Table 1 ). This result is expected, as Trolox acts as a two-electron reductant, while GSH and cysteine only afford one electron to reduce [Cu(Nc) 2] 2+ to [Cu(Nc)2] + . For other compounds, gallic and caffeic acids exhibit a TAC value three times higher than Trolox, when compared at end-point conditions.
The kinetic profile of the standard compound (Fig. 3) is not relevant when end-point measurements are performed, as shown for two urine samples ( Table 2 , results for 30 min). Using either Trolox, uric acid, GSH or gallic acid, one finds that the CUPRAC values attained after 30 min of reaction are quite similar when corrected for the number of electrons transferred by each standard compound, calculated as the CUPRAC value multiplied by the ratio between the slope attained for the standard compound and the slope obtained for Trolox, both for 30 min of reaction (Table 1) , and expressed as CUPRAC in Trolox equivalents (Table 2 ). However, whenever measurements are taken before a stable absorbance value is achieved (4 min in our case, Table 2 ), CUPRAC values are underestimated when fast reacting compounds (Trolox and GSH, in this case) are chosen as standards, providing a CUPRAC value about 30% lower for 4 min when compared to end-point measurements (at 30 min). Nevertheless, when a compound with a kinetic behavior similar to that presented by the sample is chosen, end-point CUPRAC values can be attained much earlier, as shown in Table 2 for uric acid. In this case, relative deviations a. Results are expressed as equivalents of standard compound (mM) ± standard deviation (n = 4). b. CUPRAC value expressed in Trolox equivalents by multiplying the value presented for 30 min of reaction and the slope ratio between the standard compound and Trolox given in Table 1 .
were -0.5% (sample 1) and +2.7% (sample 2) when comparing results attained at 4 and 30 min. Hence, we propose here a novel strategy to reach end-point values in a faster way by choosing a standard compound that presents a kinetic behavior as similar as possible to that presented by the sample.
Figures of merit and application to human biological samples
Though Trolox is frequently applied as the standard compound, uric acid was chosen here as the standard compound, as it is one of the main antioxidant components in biological samples and because it presents a kinetic profile similar to initially tested urine samples (Table 2) . Hence, figures of merit including detection limit, precision, reproducibility and sample throughput were determined for CUPRAC-FIA method and also for high-throughput CUPRAC microplate method (reaction time of 4 min).
The detection limit was calculated as the concentration corresponding to the intercept value plus three times the statistic sy/x. 35 For 6 different calibration curves, the calculated detection limit obtained for the CUPRAC-FIA methodology was about 11 μM of uric acid. The precision (repeatability) was estimated by calculating the relative standard deviation (RSD) from 10 consecutive determinations of a uric acid standard solution (50 μM), providing a value of 0.98%. The reproducibility of the developed method, assessed by the RSD of calibration slopes performed in different days (n = 6), was 2.8%. Finally, the CUPRAC-FIA method allowed about 15 determinations per hour, fostering automatic TAC assessment in 5 samples per hour when performed in triplicate.
For the high-throughput microplate method, the detection limit was 3 μM of uric acid, estimated from 6 calibration curves. The precision (RSD) was 1.0% (50 μM uric acid solution, n = 4) while the reproducibility was 6.1%, calculated as described above. Sample throughput was clearly enhanced as 96 determinations could be performed in 4 min, requiring a previous incubation time of 15 min at 37 C. Hence, determination throughput was 288 h -1 while sample throughput was 72 h -1 when performed in quadruplicate. The developed methodologies were applied to human biological samples, including serum and urine. For human serum (SRM 909b, level I, diluted 1:75), TAC values of 1.20 ± 0.02 and 1.23 ± 0.02 (expressed as equivalents of uric acid in mM) were attained for CUPRAC-FIA and end-point batch CUPRAC methods, respectively. These results were not significantly different (tcalc = 1.964, ttab = 2.571, ν = 5, α = 0.05), 35 indicating that the assay time can be shortened to 4 min when uric acid is applied as standard compound.
This was further verified for urine samples, for which results are presented in Table 3 as mean pool values attained for samples diluted 1:20, 1:40 or 1:60. In this case, results obtained by CUPRAC-FIA and the end-point batch method were also in agreement. A linear relationship between these results was established as CFIA = 1.034(± 0.036)Cend-point + 0.047(± 0.064), R = 0.9993, where values in parentheses are 95% confidence limits, indicating that the estimated slope and intercept do not differ significantly for 1 and 0, respectively. 35 Furthermore, when comparing the results between end-point batch method and uric acid equivalents attained after 4 min of reaction, we obtained the following relationship: C4min = 0.986(± 0.044)× Cend-point + 0.030(± 0.080), R = 0.9988. This also indicates that there is no significant difference between these two sets of results.
In order to assess the potential of CUPRAC-FIA method to account for the presence of dietary phenolic compounds in urines, we spiked one sample with 10 or 100 μM of caffeic acid.
Recovery values of 139 and 99% were attained for each level tested, showing the potential of this method for assessing urine TAC in nutritional studies.
Finally, the CUPRAC-FIA method provides measurement of total antioxidant capacity, which can be more useful for assessing biological oxidative status than the targets of previously reported automatic methods that aimed at assessing scavenging capacity against a given species, namely NO, 36, 37 or H2O2, ClO -, O2 • -, and 1 O2. 37 Compared to previously described automatic flow systems for TAC, this CUPRAC-FIA system is not invasive, 38 requiring a minimum amount of sample (between 2.7 and 10 μL per analysis, considering dilution factors between 75 and 20 times, respectively). Low reagent consumption per determination was also attained, comprising 8.1 μM of Cu(II), 6.1 μM of neocuproine and 0.81 mM of ammonium acetate, which gives a cost per determination of 0.023 euros.
Conclusion
The CUPRAC-FIA and the microplate CUPRAC methods presented in this work allowed the in vitro assessment of antioxidant capacity of endogenous and dietary molecules and also the determination of total antioxidant capacity of human biological samples. Through the appropriate selection of standard compound it was possible to decrease by 7.5 times the analysis time, from the original 30 to 4 min, providing high-throughput results under the microplate format. The automation by CUPRAC-FIA method allowed for reduced intervention by an operator, which is a special requirement in the research/clinical biochemistry field. Moreover, the FIA manifold described here is extremely simple to implement in routine laboratories, easily operated and is also cost-effective, making it an attractive and suitable tool for two possible application areas. First, it can be used for screening biological activity in food products, plant extracts or pharmaceutical compounds and, secondly, it can be used in clinical trials and epidemiological studies as a routine test for biological fluids in order to evaluate and follow up the level of oxidative status. 
